Filing Details
- Accession Number:
- 0001128732-16-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-26 08:49:58
- Reporting Period:
- 2016-04-12
- Filing Date:
- 2016-04-26
- Accepted Time:
- 2016-04-26 08:49:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1402328 | Sunshine Biopharma Inc | SBFM | Services-Commercial Physical & Biological Research (8731) | 205566275 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1474684 | N. Steve Slilaty | 579 Rue Lajeunesse Laval A8 H7X 3K4 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-12 | 253,082 | $0.20 | 30,570,776 | No | 4 | P | Indirect | Owned by Advanomics Corporation, an entity controlled by Reporting Person. |
| Common Stock | Acquisiton | 2016-04-22 | 12,000,000 | $0.01 | 12,384,373 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Owned by Advanomics Corporation, an entity controlled by Reporting Person. |
| No | 4 | A | Direct |
Billionaire Hedge Funds
